Kantor T G
Am J Med. 1986 Apr 28;80(4B):64-9. doi: 10.1016/0002-9343(86)90083-5.
The inhibition of prostaglandin synthesis by nonsteroidal anti-inflammatory drugs can alleviate the pain and inflammation associated with a variety of disorders. Nonsteroidal anti-inflammatory drugs have a role, therefore, in the treatment of nonrheumatic conditions as well as in the treatment of rheumatic diseases, an area in which these agents have been used and studied more extensively. In clinical conditions marked by acute or chronic pain and inflammation, such as oral surgery, dysmenorrhea, low back pain, renal colic, and biliary colic, as well as in post-traumatic and postoperative conditions, diclofenac sodium, a nonsteroidal anti-inflammatory drug with potent prostaglandin synthetase inhibition, has been shown to be an effective analgesic agent. In the current studies, diclofenac was given orally or by intramuscular injection in doses ranging from 50 to 75 mg daily, or up to 150 mg per day for longer-term use. When compared with placebo, diclofenac provided consistently superior relief of symptoms. Comparisons with other nonsteroidal anti-inflammatory drugs or with opioids, such as pentazocine or Spasmofen, demonstrate that symptom relief with diclofenac was either comparable to or better than that obtained with these agents.
非甾体抗炎药对前列腺素合成的抑制作用可减轻与多种病症相关的疼痛和炎症。因此,非甾体抗炎药在非风湿性疾病的治疗以及风湿性疾病的治疗中均有作用,在风湿性疾病领域,这些药物的使用和研究更为广泛。在以急性或慢性疼痛和炎症为特征的临床病症中,如口腔手术、痛经、腰痛、肾绞痛和胆绞痛,以及创伤后和术后情况,双氯芬酸钠作为一种具有强效前列腺素合成酶抑制作用的非甾体抗炎药,已被证明是一种有效的镇痛药。在当前研究中,双氯芬酸通过口服或肌肉注射给药,剂量为每日50至75毫克,长期使用时每日剂量可达150毫克。与安慰剂相比,双氯芬酸能持续更有效地缓解症状。与其他非甾体抗炎药或阿片类药物(如喷他佐辛或斯帕莫芬)相比,结果表明双氯芬酸缓解症状的效果与这些药物相当或更佳。